Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Bogenschutz, Michael P, Forcehimes, Alyssa A, Pommy, Jessica A, Wilcox, Claire E, Barbosa, PCR, Strassman, Rick J · 2015 · Journal of Psychopharmacology

Abstract

Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically relevant effects in alcohol and drug addiction. Although recent studies have investigated the effects of psilocybin in various populations, there have been no studies on the efficacy of psilocybin for alcohol dependence. We conducted a single-group proof-of-concept study to quantify acute effects of psilocybin in alcohol-dependent participants and to provide preliminary outcome and safety data. Ten volunteers with DSM-IV alcohol dependence received orally administered psilocybin in one or two supervised sessions in addition to Motivational Enhancement Therapy and therapy sessions devoted to preparation for and debriefing from the psilocybin sessions. Participants’ responses to psilocybin were qualitatively similar to those described in other populations. Abstinence did not increase significantly in the first 4 weeks of treatment (when participants had not yet received psilocybin), but increased significantly following psilocybin administration ( p < 0.05). Gains were largely maintained at follow-up to 36 weeks. The intensity of effects in the first psilocybin session (at week 4) strongly predicted change in drinking during weeks 5–8 ( r = 0.76 to r = 0.89) and also predicted decreases in craving and increases in abstinence self-efficacy during week 5. There were no significant treatment-related adverse events. These preliminary findings provide a strong rationale for controlled trials with larger samples to investigate efficacy and mechanisms. TRIAL REGISTRATION: NCT02061293

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881114565144

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

17 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 94 references

Research works printed but not linked: 13

  1. Anisman H, 2008, J Psychiatry Neurosci, 33, 131
  2. Buckholtz NS, 1990, Neuropsychopharmacology, 3, 137
  3. Fetzer Institute, 1999, Multidimensional Measurement of Religiousness/Spirituality for Use in Health Research
  4. First MB, 1996, Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (Scid-I/P, Version 2.0)
  5. First MB, 1997, Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition
  6. Grof S, 2008, LSD Psychotherapy
  7. Leuner H, 1967, The Use of LSD in Psychotherapy and Alcoholism, 101
  8. Pahnke WN, 1969, Int Psychiatry Clin, 5, 149
  9. Pahnke WN, 1969, Curr Psychiatr Ther, 9, 144
  10. Richards WA, 1975, Counseling, peak experiences and the human encounter with death: An empirical study of the efficacy of DPT-assisted counseling in enhancing the quality of life of persons with terminal cancer and their closest family members
  11. Schwartz SH, 2006, Revue française de sociologie, 42, 249
  12. Sherwood JN, 1962, J Neuropsychiatr, 4, 69
  13. Wiesbeck GA, 1999, Alcohol Clin Exp Res, 23, 230

Cited by

See all 1,151

Metadata

Authors
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J.
Affiliations
  • University of New Mexico Health Sciences Center (US)
  • Department of Psychiatry, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
  • Universidade Estadual de Santa Cruz (BR)
Venue
Journal of Psychopharmacology
Published
2015-01-13
Volume
29
Issue
3
Pages
289-299
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2075238613
Cited by
1,151
References
94
Citations by year
2026: 73 · 2025: 154 · 2024: 152 · 2023: 156 · 2022: 161 · 2021: 137 · 2020: 105 · 2019: 46 · 2018: 64 · 2017: 43 · 2016: 47 · 2015: 11
FWCI
68.30
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • UNM’s Digital Repository (University of New Mexico) (submittedVersion)
Funders
  • Johns Hopkins University
  • Heffter Research Institute
  • Lundbeckfonden
  • National Institutes of Health
  • National Center for Research Resources (UL1RR031977)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
psilocybin, alcoholism, hallucinogens, motivational enhancement therapy, alcohol abstinence, craving, abstinence self-efficacy, treatment safety
MeSH terms
Adult, Alcohol Drinking, Alcoholism, Combined Modality Therapy, Female, Follow-Up Studies, Hallucinogens, Humans, Male, Middle Aged, Motivation, Psilocybin, Time Factors, Cognitive Behavioral Therapy, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. https://app.cochat.ai/papers/10.1177/0269881114565144
The paper
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology. https://doi.org/10.1177/0269881114565144

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.